Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

The startup aims to create a platform for treating extremely rare genetic mutations, armed with CRISPR advances and new regulatory pathways.

Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments for rare conditions by using the agency’s “plausible mechanism” pathway.

The human brain is often compared to a computer, but the latest wave of research shows it is closer to a self-building city, ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for ...

In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...

This article was produced in partnership with Regeneron by Scientific American Custom Media, a division separate from the magazine’s board of editors. In the long-running quest to improve on ...

Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...

Beginning a chain of events that will presumably lead to the origin of our universe's Spider-Man, researchers in Germany have created the world's first spiders to be genetically modified using CRISPR ...